Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder.
about
Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expressionCyclooxygenase-1 and -2 expression in urothelial carcinomas of the urinary bladder in cows.Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene.FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanisms.Role of COX-2 inhibitors in cancer therapy.Molecular prognostic factors in bladder cancer.Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.Expression of cyclooxygenase-2 (COX-2) in pituitary tumours.The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder.COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivoRole of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies.Inflammation and cancer: how friendly is the relationship for cancer patients?Co-expression of cox-2, C-met and beta-catenin in cells forming invasive front of gallbladder cancer.Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England.Management of upper urinary tract urothelial carcinoma.Advances in biomarkers for esophageal cancer.Predictive markers in bladder cancer: do we have molecular markers ready for clinical use?Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.Artesunate induces apoptosis of bladder cancer cells by miR-16 regulation of COX-2 expression.Odontogenic epithelial proliferation is correlated with COX-2 expression in dentigerous cyst and ameloblastomaInhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells.Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells.Down-regulation of cyclooxygenase-2 expression but up-regulation of cyclooxygenase-1 in renal carcinomas of the Eker (TSC2 gene mutant) rat model.Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer.Cyclooxygenase-2 and survivin in superficial urothelial carcinoma of the bladder and correlation with intratumoural microvessel density.Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.Cyclo-oxygenase-2 expression in esophageal adenocarcinoma as a determinant of clinical outcome following esophagectomy.Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder.
P2860
Q24684962-364A5E1B-FA79-45A8-BD4A-19A9A52E1EC2Q30952052-43AB29E1-D516-44BC-B025-39053E85B0B1Q33552763-752D941D-6059-46A9-87AB-99927D6D8A6BQ34305855-19C0754B-E1BE-49D8-BAC4-27F7BAF0108BQ35806751-90EA64C4-B45B-4708-AF85-99339AF9B161Q36082097-0C2DA09A-9B15-4D1B-9E48-57E8F14DDB66Q36194125-9C9AB864-CEA1-49E4-9CBB-B78BFC543B3BQ36232504-4159535F-7F94-48F4-84FE-CC8BB357FAD1Q36577742-7FA95D14-4AC8-499D-AA7E-AA7BDB8CDFE5Q36611805-8E43A558-61E1-4D74-8C33-CD76F1FA3F5FQ36694470-0AB2EC7B-40D3-4693-8086-A78B00778D7FQ36900405-21D8A5AF-6A4D-4B87-A66C-A3AE4053F979Q37202773-3AEE117D-CD37-41AC-A305-12DE059304EFQ37316105-6D108CDB-1155-4EA1-8677-F0B02F8790FFQ37446964-CF7A937A-07A8-40B8-A177-AAF6851A4106Q37632955-23B0219E-E0FA-4D05-BE70-C873DCABC9E4Q37812609-0E453C2E-0CEE-43D8-A491-B43A13366904Q38153443-F7383581-8748-44B3-AE22-01214DCBB391Q38230912-2234BED2-7877-4A5F-8A85-F876BD859BB7Q38413564-E7CE2941-25DC-40C7-8606-BD7FF86F8DB1Q38958952-CE3CD9D6-8C1B-44D4-90B5-4C43FC4B3749Q38998679-C752CBED-EA1F-431A-B210-27D71AA187ABQ40244603-AF696D77-3195-40EE-8C69-AB0F4D274604Q40626539-29FE4FB0-EE1F-439B-8278-33E24DF0FE32Q40653146-C3BD0A76-8401-4BA8-80EA-784356025F20Q42145392-4EB21EE0-5637-41BD-A6FE-DAB51661E571Q43672969-BDB75CA9-5622-4B3D-8279-E9DFBA3DFE56Q44464279-879A941D-6185-4190-BF13-B3BDE55CB4CFQ47257210-BE0095A0-805F-4AEF-BE8C-5C1FEAD94880Q51738913-EA448394-D9FA-495E-847A-78630322183FQ53093929-74475462-72C2-4FB3-B0EC-C5F98E8C617A
P2860
Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Relation between cyclooxygenas ...... cinoma of the urinary bladder.
@en
Relation between cyclooxygenas ...... cinoma of the urinary bladder.
@nl
type
label
Relation between cyclooxygenas ...... cinoma of the urinary bladder.
@en
Relation between cyclooxygenas ...... cinoma of the urinary bladder.
@nl
prefLabel
Relation between cyclooxygenas ...... cinoma of the urinary bladder.
@en
Relation between cyclooxygenas ...... cinoma of the urinary bladder.
@nl
P2093
P2860
P1433
P1476
Relation between cyclooxygenas ...... cinoma of the urinary bladder.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20010701)92:1<188::AID-CNCR1308>3.0.CO;2-W
P407
P577
2001-07-01T00:00:00Z